Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke (DASH)
15 de mayo de 2026 actualizado por: Bruyère Health Research Institute.
Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke: An Effectiveness-implementation Hybrid Trial.
The goal of this clinical trial is to learn if a home visit by a trained volunteer can improve stroke recovery after a stroke survivor is discharged home from the hospital. The main questions it aims to answer are:
- After 3 months of being discharged from the hospital, does this additional volunteer support at home improve coping skills for stroke survivors?
- Does the effects of the volunteer support last over 3 to 6 months after being discharged home?
Researchers will compare between a group who will receive the volunteer support and a group who will not to see if the additional support can improve stroke recovery.
Participants will:
- Either receive volunteer support over an 8-week time period OR receive no additional volunteer support
- Continue with their usual care plan and receive educational resources from the research team during the study
- Complete online surveys during study enrollment, at 3 months, and at 6 months after hospital discharge
Descripción general del estudio
Estado
Aún no reclutando
Intervención / Tratamiento
Descripción detallada
Acute stroke often leads to adult disability in Canada, and about 108,707 Canadians experience a stroke each year.
While most people survive stroke (80 percent) and return home, some survivors are left with ongoing challenges that require them to seek help in the community.
These challenges can lead to stress for the individual and their caregiver.
Research on volunteer-supported home-to-hospital programs has shown positive outcomes.
However, despite the growing evidence that supports volunteer engagement in care transitions, we have yet to determine the impact of a complex psychosocial volunteer-delivered care transition intervention for stroke survivors.
This study will assess whether a volunteer-delivered transitional care intervention, designed by Bruyère Health Research Institute in partnership with March of Dimes Canada (MODC), for adults discharged home from a stroke rehabilitation unit following an acute stroke can improve coping compared to usual care.
MODC will implement the volunteer-support transition program across two Ontario regions for stroke rehabilitation sites.
Those allocated to the intervention group will receive an initial visit from the Volunteer Coordinator and then weekly one-on-one visits by a trained volunteer for eight weeks.
The volunteer may assist the study participant with instrumental daily living activities and psychosocial and informational support.
Those not receiving the intervention will receive educational material at 4- and 8-week time points in addition to their usual care.
All study participants will complete validated patient-reported outcome measures at 3- and 6-months post-hospital discharge.
Tipo de estudio
Intervencionista
Inscripción (Estimado)
840
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Michelle LA Nelson, MA, PhD, FAHA, FWSO
- Número de teléfono: 647-938-4425
- Correo electrónico: mla.nelson@uottawa.ca
Copia de seguridad de contactos de estudio
- Nombre: Research Coordinator
- Correo electrónico: TMoni@bruyere.org
Ubicaciones de estudio
-
-
Ontario
-
Ottawa, Ontario, Canadá
- Bruyère Health Élisabeth-Bruyère Hospital
-
Toronto, Ontario, Canadá
- Sunnybrook Health Sciences Centre
-
Toronto, Ontario, Canadá
- Hennick Bridgepoint Hospital
-
Toronto, Ontario, Canadá
- Providence Healthcare (Unity Health Toronto)
-
Toronto, Ontario, Canadá
- Toronto Rehabilitation Institute (UHN)
-
Toronto, Ontario, Canadá
- West Park Healthcare Centre (UHN)
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- Confirmed diagnosis of stroke
- Either undergoing or recently completed in-patient rehabilitation within the last 3 weeks
- Lived at home pre-stroke
- Discharged directly home (to own residence or that of a family member)
- Live in one of the program implementation areas (i.e., Toronto, Ottawa)
Exclusion Criteria:
- Discharged to additional hospital inpatient care, nursing home, or other long-term care
- Inability to communicate in English
- Inability to provide informed consent due to cognitive deficits
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Group A: DASH group
Participants will receive the DASH intervention + Usual Care + Educational Resources
|
One-on-one weekly visits in the stroke survivor participants' residence by a trained volunteer for approximately 8 weeks (about 2 months). Volunteer support could span three types: i) instrumental activities of daily living assistance (e.g., assistance with meal preparation, light house duties, and transportation), ii) psychosocial support (e.g., befriending visits), and iii) informational supports (signposting to other community services). |
|
Sin intervención: Group B: Usual care group
Participants will receive the Usual Care + Educational Resources
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Coping at Time 1 as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
Periodo de tiempo: Measured at 3 months post-hospital discharge
|
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported outcome measure evaluating perceived difficulty coping following hospital discharge.
Each item is scored on a scale from 0 to 10. Item scores are summed to yield a total score ranging from 0 to 100, with higher scores indicating greater difficulty coping.
|
Measured at 3 months post-hospital discharge
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in coping as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
Periodo de tiempo: Measured at 3 months and 6 months post-hospital discharge
|
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported measure.
Each item is scored from 0 to 10, with total scores ranging from 0 to 100.
Change in total score will be calculated between time points.
Higher scores indicate greater difficulty coping.
|
Measured at 3 months and 6 months post-hospital discharge
|
|
Change in quality of life as assessed by Stroke-Specific Quality of Life (SS-QOL)
Periodo de tiempo: Measured at 3 months and 6 months post-hospital discharge
|
Quality of life will be assessed using the Stroke-Specific Quality of Life (SS-QOL) scale, a 49-item patient-reported measure evaluating multiple domains of health-related quality of life in stroke survivors.
Each item is scored on a 5-point Likert scale (1 to 5).
Domain scores are calculated as the average of items within each domain, and the overall score is calculated as the average of all domain scores or as the sum of all 49 items (ranging 49 to 245).
Higher scores indicate better quality of life.
|
Measured at 3 months and 6 months post-hospital discharge
|
|
Change in symptoms of depression as assessed by Patient Health Questionnaire-9 (PHQ-9)
Periodo de tiempo: Measured at 3 months and 6 months post-hospital discharge
|
Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9), a 9-item patient-reported measure.
Each item is scored from 0 to 3, resulting in a total score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
|
Measured at 3 months and 6 months post-hospital discharge
|
|
Change in social isolation and loneliness indicators as assessed by UCLA Loneliness Scale (Version 3)
Periodo de tiempo: Measured at 3 months and 6 months post-hospital discharge
|
Social isolation and loneliness will be assessed using the UCLA Loneliness Scale (Version 3), a 20-item patient-reported measure evaluating subjective feelings of loneliness and social isolation.
Each item is scored on a 4-point scale.
Total scores range from 20 to 80, with higher scores indicating greater loneliness.
|
Measured at 3 months and 6 months post-hospital discharge
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
1 de junio de 2026
Finalización primaria (Estimado)
1 de enero de 2028
Finalización del estudio (Estimado)
1 de abril de 2028
Fechas de registro del estudio
Enviado por primera vez
11 de mayo de 2026
Primero enviado que cumplió con los criterios de control de calidad
11 de mayo de 2026
Publicado por primera vez (Actual)
15 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
18 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
15 de mayo de 2026
Última verificación
1 de mayo de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 191308
- 5161 (Otro identificador: Clinical Trials Ontario)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
INDECISO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .